Related Experiment Video
Updated: May 6, 2026

09:54
Laboratory Scale Production and Purification of a Therapeutic Antibody
Published on: January 24, 2017
17.4K
Digital design of an integrated purification system for continuous pharmaceutical manufacturing
Inyoung Hur1, Daniel Casas-Orozco1, Daniel Laky1
1Davidson School of Chemical Engineering, Purdue University, West Lafayette, IN 4797 USA.
Summary
This study introduces dynamic models for continuous pharmaceutical manufacturing processes, enabling digital design of intensified carousel systems for tailored product properties and enhanced efficiency.
Area of Science:
- Pharmaceutical Engineering
- Process Systems Engineering
- Chemical Engineering
Background:
- Continuous manufacturing offers intensified processes for pharmaceutical production.
- Integrated processing steps like crystallization, filtration, and drying are key to efficiency.
- Digital design and modeling tools are crucial for optimizing complex pharmaceutical processes.
Purpose of the Study:
- To develop dynamic models for continuous crystallization, filtration, deliquoring, washing, and drying.
- To enable the digital design and simulation of an integrated continuous two-stage crystallization and filtration-drying carousel system.
- To investigate the impact of model uncertainty on optimal operating conditions.
Main Methods:
- Development of dynamic models within the open-source pharmaceutical modeling tool PharmaPy.
- Simulation of an integrated continuous two-stage crystallization and filtration-drying carousel system.
- Analysis of improved crystallization design on downstream operations and process efficiency.
Main Results:
- Improved crystallization design enhances critical material attributes, boosting filtration and drying efficiency.
- Digital design of the integrated process achieves higher productivity while meeting quality constraints.
- PharmaPy facilitates systematic process development, including design space identification and robust operation optimization.
Conclusions:
- PharmaPy enables the digital design and optimization of intensified continuous pharmaceutical manufacturing systems.
- Optimized process design leads to enhanced productivity and tailored product attributes.
- The developed models support improved process understanding and robust operational strategies.
Related Concept Videos
Bioreactor Design and Operational System
223
Bioreactors are engineered vessels designed to cultivate microorganisms under controlled conditions for industrial bioprocessing. They maintain sterility and allow precise regulation of pH, temperature, oxygen, and nutrient levels to optimize microbial growth and metabolite production. Bioreactors range from small laboratory units of 1 liter to industrial systems holding up to 500,000 liters, though only about 75% of their volume is actively used for fermentation. The remaining headspace...
223
Batch vs Continuous Culture
248
Fermentation is a foundational biotechnological process used to produce pharmaceuticals, biofuels, enzymes, and food additives. Among industrial strategies, batch and continuous fermentation are the two most widely applied. Although both rely on microbial conversion of substrates into desired products, they differ markedly in operation, productivity, and suitability for specific applications.Batch fermentation occurs in a closed system in which nutrient media and inoculum are added at the...
248
Scale-Up Processes
119
The scale-up of microbial fermentation processes is essential in industrial biotechnology, allowing the transition from laboratory-scale experiments to commercial-scale production while aiming to maintain product yield and quality. This process requires meticulous adjustment of equipment design, process parameters, and contamination control strategies to accommodate increasing culture volumes.At the laboratory scale, cultures are typically maintained in 1 to 10-liter glass or autoclavable...
119
Upstream Processing
103
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
103

